Overview

L-Glutamine Therapy for Sickle Cell Anemia

Status:
Terminated
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The primary purpose is to evaluate the effect of L-glutamine therapy on exercise endurance and breath by breath exercise response of sickle cell anemia patients The secondary purpose is to assess the effect of L-glutamine on incidence of painful crises; level of chronic pain, and amount of daily requirement for narcotics.
Phase:
Phase 2
Details
Lead Sponsor:
Los Angeles Biomedical Research Institute
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Collaborator:
Emmaus Medical, Inc.